iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Sometimes—but first clarify what “circular DNA” means. Extrachromosomal circular DNA (ecDNA) is found in cancer cells, while circulating tumor DNA (ctDNA) is tumor-derived DNA measured in blood. Selected ctDNA tests can inform care in specific settings, but the evidence here does not establish routine ecDNA testing as a way to choose treatment.
What does “circular DNA testing” mean?
The phrase can refer to two different things. The test’s target matters: a finding about ecDNA biology is not the same as a ctDNA blood-test result.
| Term | What it refers to | What the cited evidence supports |
|---|---|---|
| ecDNA | Circular DNA structures outside chromosomes in tumor cells. | A 2025 American Association for Cancer Research review describes ecDNA as a way cancer cells can carry amplified genes, including oncogenes, and discusses its relevance to tumor evolution and drug resistance. The review is about biology and research tools; it does not establish a routine ecDNA-guided treatment pathway. Read the AACR review. |
| ctDNA | Tumor-derived DNA fragments found in blood and assessed through a liquid biopsy. | National Cancer Institute (NCI) guidance describes biomarker testing, including liquid biopsy, as a way that may help clinicians select treatment or identify a relevant clinical trial. A ctDNA assay may look for tumor-associated variants or molecular residual disease (MRD) in particular clinical contexts. Read NCI’s biomarker-testing guidance. |
The AACR review reports ecDNA in 17% of all cancers and says its presence is associated with worse patient outcomes. That is a finding about reported ecDNA prevalence and outcomes—not the share of patients who need an ecDNA test, nor evidence that testing selects a treatment that improves outcomes. AACR review.
How can a ctDNA result affect a treatment decision?
Biomarker testing can help an oncology team consider a treatment or a clinical trial when a result is relevant to the patient’s cancer and to a specific treatment option. NCI notes that a matched option may be an approved therapy, an off-label treatment, or participation in a clinical trial. A result is one part of that decision; it does not by itself prescribe treatment or guarantee that a suitable option exists. NCI guidance on biomarker testing.
#1 Best Overall
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
“Biomarker testing,” “tumor genetic testing,” “genomic testing,” “molecular profiling,” and “liquid biopsy” can overlap in clinical discussions, but they are not interchangeable names for ecDNA testing. Ask which analyte the test measures, what the assay is intended to detect, and how the result connects to a treatment option.
What uses are established, and what is still being studied?
FDA guidance on ctDNA in drug development
The U.S. Food and Drug Administration’s final November 2024 guidance addresses ctDNA as a biomarker in clinical trials and drug development for early-stage solid tumors treated with curative intent. It discusses assay and MRD considerations in that development setting. It is not a general instruction to change an individual patient’s care based on a ctDNA result. Read the FDA guidance.
Rank #2
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
A treatment-linked test for a defined indication
The FDA approval record for Signatera CDx describes a personalized, tumor-informed ctDNA MRD assay. Its listed intended use is in muscle-invasive bladder cancer to identify patients who may benefit from the therapy specified in that therapy’s approved labeling. This is an indication-specific example; it does not establish the same use for every ctDNA test, cancer, or treatment decision. Check the FDA approval record.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Questions being tested in clinical trials
NCI’s MRD-PORT trial listing describes a study of whether ctDNA results can guide treatment for stage II–III non-small cell lung cancer. A separate NCI listing describes a study of blood-based ctDNA testing and treatment suggestions in advanced or metastatic cancers. These are investigations in defined settings, not proof that ctDNA testing guides treatment successfully across cancers. Trial status can change, so consult the live listing for current status. MRD-PORT trial listing · NCI treatment-suggestions trial listing.
Rank #3
- ABOUT THE TEST: The Genetrace DNA Paternity Test helps families conclusively determine if a man is the true father of a child.
- NO HIDDEN FEES: Kit includes all lab fees and sample return costs to test one (1) child and one (1) potential father.
- FAST RESULTS: Get secure, confidential results within 1-2 business days after testing begins. We'll keep you updated every step of the way.
- EASY SAMPLE COLLECTION: No needles, no blood, no doctors. Collect your samples with our easy-to-use mouth swabs, then return them to the lab with the provided prepaid return envelope. It's quick, easy & painless.
- ACCURATE & RELIABLE: Up to 27 genetic markers analyzed for over 99.999% accuracy. All tests performed TWICE in our AABB, ISO 17025 & CLIA accredited laboratory.
How should you assess a test or treatment claim?
When someone says a DNA test can guide treatment, check the details that determine whether the claim applies to a particular patient:
- What is measured? Is the test looking for ecDNA in tumor cells, ctDNA in blood, or another biomarker?
- Which cancer and stage? Evidence for one cancer or stage does not automatically apply to another.
- What is the test intended to do? Distinguish a test with a treatment-linked intended use from one being studied in a trial or used for a different purpose.
- What is the treatment link? Ask which specific therapy the result is meant to inform and whether the test’s intended use matches that therapy’s approved labeling.
- What kind of evidence supports it? A regulatory approval record, drug-development guidance, and a clinical-trial listing answer different questions; a trial listing alone is not proof of clinical benefit.
- Who will interpret the result? Review what the result means and what options, if any, follow from it with the oncology team.
What can’t be concluded from these examples?
The sources cited here do not provide a head-to-head comparison of ctDNA assays, comparative sensitivity or accuracy, survival benefit across testing strategies, or broad coverage and reimbursement information. They also do not establish routine ecDNA testing for treatment selection. A claim about a test should therefore be checked against the specific assay, cancer, stage, intended use, and linked therapy—not generalized from the word “circular” or from a result in a different setting.
Quick Recap
Best Value
- About HomePaternity: This DNA test will conclusively determine if a man is the biological father of a child using a simple at-home kit including cheek swabs from the father and child.
- Fast Results: Your kit includes Overnight FedEx return to the lab and results will be available within 1-2 days after your sample arrives, in our secure online portal.
- Over 99.999% Confidence: With up to 34 genetic markers examined, we confirm paternity with the highest accuracy, typically 99.999%+. Tests are run twice in our lab, which has obtained over 6 certifications.
- Easy Sample Collection: Collect your samples with mouth swabs, then return in the pre-paid Overnight mailer. Includes testing for 1 child and 1 possible father; can add more participants after kit registration.
- Internal Lab: With over 25 years of experience and over 20 million tests performed, we don’t use third-party labs.
Rank #4
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Ancestry Composition breaks down your ethnicity across 5,000+ geographic regions worldwide, the most detailed ancestry breakdown of any consumer DNA service. Ancestry Timeline estimates how many generations ago your most recent ancestor from each population lived.
- FIND LIVING RELATIVES: Opt in to DNA Relatives to see up to 1,500 people in the 23andMe database who share DNA with you, from close family to distant cousins, and message them directly. Your Family Tree builds itself automatically based on your DNA.
- DISCOVER WHAT MAKES YOU UNIQUE: See how your DNA may influence physical features, sensory preferences, and habits across 30+ traits, including cilantro taste aversion to hair texture to deep sleep.
- TRACE ANCIENT MIGRATIONS: Maternal and Paternal Haplogroup reports follow your ancestors' migration paths across continents over thousands of years (paternal haplogroup requires a Y chromosome). Find out how much of your ancestry can be traced back to the Neanderthals.
- PRIVATE BY DESIGN: Your DNA data is encrypted, protected, and always under your control. Enhanced security measures are implemented to keep your information safe. Subject to 23andMe’s Terms of Service and Privacy Statement at 23andMe online.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
